No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Experienced Executives Art Collins Is Appointed Senior Advisor of ExplORer Surgical and Denis Harrington to BOD

Former CEOs of Medtronic and BridgePoint Medical to advise ExplORer Surgical’s executive team and help advance its growth in the Med Device industry

Editor: What To Know

  • He also served as a member of the Board of Overseers of the Wharton School at the University of Pennsylvania and as chairman of AdvaMed, the medical technology industry association.
  • Collins' and Harrington's decades of commercial and entrepreneurial experience in the medical device field provide ExplORer Surgical and its executive team a valuable resource to help direct the company’s strategy.
  • Harrington is the owner of Denis L Harrington Consulting, LLC, a management and strategy consulting firm he established after nearly 30 years of successful leadership in the medical device industry.

October 13, 2020

Art Collins, former chairman and CEO of Medtronic, has been appointed senior advisor of ExplORer Surgical and Denis Harrington, former CEO of BridgePoint Medical, has been appointed to its Board of Directors. Collins’ and Harrington’s decades of commercial and entrepreneurial experience in the medical device field provide ExplORer Surgical and its executive team a valuable resource to help direct the company’s strategy.

Art Collins has over 30 years of experience in the medtech industry, first with Abbott Laboratories and later with Medtronic where he served as chairman & CEO from 2001 to 2008. During his 15-year tenure as CEO and COO of Medtronic, revenues and earnings per share grew at a compounded growth rate of over 15 percent. He is currently a member of Boeing’s board of directors and is a past director of Alcoa, Arconic, Cargill, Tennant, and US Bancorp. He also served as a member of the Board of Overseers of the Wharton School at the University of Pennsylvania and as chairman of AdvaMed, the medical technology industry association.

“We all know that 2020 has created a new normal for hospitals and medtech companies as they increasingly embrace remote and digital technology. ExplORer was well-positioned before the pandemic, and this year has accelerated the demand for their cutting-edge platform that helps ensure best practices and streamlines workflows to better ensure procedural proficiency,” said Collins. “I believe the company is well-positioned to achieve rapid growth and I am looking forward to my association with them.”

Harrington is the owner of Denis L Harrington Consulting, LLC, a management and strategy consulting firm he established after nearly 30 years of successful leadership in the medical device industry. He previously served as CEO for BridgePoint Medical and NexGen Medical, successfully leading BridgePoint from its development stage through commercialization and successful acquisition by Boston Scientific. Currently, he serves as an executive consultant and board director for several medical device companies.

“I am excited to join ExplORer Surgical’s Board of Directors,” said Harrington.  “I have spent over 30 years in the medical device business, and I am extremely impressed by ExplORer’s potential. As the healthcare ecosystem rapidly evolves and changes, platforms like ExplORer will play an increasingly critical role in delivering insight, information, and best practices to optimize outcomes and improve efficiencies in all healthcare procedure suites. ExplORer’s ability to deliver remote coaching and constantly update itself for continuous automated improvement make it an indispensable tool for med-tech sales reps to support complex procedures and deliver optimized service.”

ExplORer provides meaningful value to an organization’s functions and the surgical teams they work with, including sales, training, medical affairs, marketing, and research and development.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy